Raffaele Costanzo Selected Research

Temozolomide (Temodar)

1/2006

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffaele Costanzo Research Topics

Disease

16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 02/2008
11	Neoplasms (Cancer) 10/2022 - 03/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 08/2014
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2006
2	Circulating Neoplastic Cells 01/2022 - 11/2012
2	Adenocarcinoma of Lung 01/2022 - 05/2013
2	Disease Progression 01/2022 - 07/2013
2	Lung Neoplasms (Lung Cancer) 07/2020 - 10/2019
2	Hemorrhage 01/2020 - 01/2016
2	Fatigue 01/2018 - 04/2010
2	Adenocarcinoma 09/2017 - 01/2016
1	Melanoma (Melanoma, Malignant) 10/2022
1	Necrosis 02/2021
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Anorexia 01/2018
1	Diarrhea 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Carcinoma (Carcinomatosis) 08/2014
1	Vomiting 02/2008
1	Neutropenia 02/2008
1	Cardiotoxicity 03/2005
1	Atrial Fibrillation 03/2005
1	Familial primary gastric lymphoma 03/2005
1	Muscular Dystrophies (Muscular Dystrophy) 03/2005
1	Cardiac Arrhythmias (Arrythmia) 03/2005
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2005
1	Lymphoma (Lymphomas) 07/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2004

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 09/2020 - 07/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 07/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2011
4	Gemcitabine FDA Link 03/2014 - 02/2008
4	Gefitinib (Iressa)FDA Link 01/2014 - 01/2011
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2014
3	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2011
2	Angiogenesis InhibitorsIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
2	pembrolizumabIBA 09/2020 - 10/2019
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2014
2	nintedanibIBA 09/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 09/2017 - 01/2016
2	EnzymesIBA 01/2016 - 04/2010
2	Pemetrexed (MTA)FDA Link 03/2014 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2010 - 02/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	TrabectedinIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	PM 01183IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2021
1	NivolumabIBA 09/2020
1	atezolizumabIBA 07/2020
1	Monoclonal AntibodiesIBA 07/2020
1	RamucirumabIBA 01/2020
1	B7-H1 AntigenIBA 10/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	AfatinibIBA 01/2016
1	CreatinineIBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Cystatin CIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 08/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2013
1	Keratin-7 (Cytokeratin 7)IBA 05/2013
1	Cetuximab (Erbitux)FDA Link 02/2012
1	Temozolomide (Temodar)FDA LinkGeneric 01/2006
1	liposomal doxorubicin (Doxil)FDA Link 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2005
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2004
1	Rituximab (Mabthera)FDA Link 07/2004

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 10/2022 - 07/2004
5	Therapeutics 01/2022 - 07/2013
2	Immunotherapy 10/2022 - 09/2020
1	Palliative Care (Palliative Therapy) 02/2021
1	General Anesthesia 02/2021
1	Segmental Mastectomy (Lumpectomy) 02/2021
1	Radical Mastectomy 02/2021
1	Mastectomy (Mammectomy) 02/2021
1	Intravenous Infusions 01/2020
1	Radiotherapy 01/2017